Who Owns BD?
BD is the master brand of Becton, Dickinson and Company (NYSE: BDX), a global medical technology company headquartered in Franklin Lakes, New Jersey. Founded in 1897, the brand covers needles, syringes, catheters, infusion and medication dispensing systems, and interventional devices. In February 2026 the parent spun off its life sciences business into Waters Corporation, leaving BD a focused MedTech company. Parent FY2025 revenue was $21.8 billion.
Parent Company
Founded
1897
Status
Publicly Traded
Headquarters
GlobalOfficial Website
Who Owns BD?
- Parent Company: Becton, Dickinson and Company
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: BDX
| Brand | Parent Company | Ownership Type |
|---|---|---|
| BD | Becton, Dickinson and Company | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
BD on AmazonAdvertisement
History of BD
- Founded: 1897
- Founders: Maxwell W. Becton, Fairleigh S. Dickinson
The brand began in 1897 when Maxwell Becton and Fairleigh Dickinson started manufacturing and selling thermometers and syringes in New York City. The company incorporated in New Jersey in 1906 and built its first plant in East Rutherford.
Through the twentieth century BD became synonymous with injection and blood collection products. The BD Vacutainer evacuated blood collection system standardized phlebotomy. Safety-engineered Sharps products positioned the brand around protecting healthcare workers from needlestick injuries.
Two acquisitions expanded the brand's hospital footprint: CareFusion in 2015 (about $12.2 billion) brought the Alaris infusion and Pyxis dispensing platforms, and C.R. Bard in 2017 (about $24 billion) added surgery, urology, and vascular interventional lines.
The February 9, 2026 completion of the Biosciences and Diagnostic Solutions combination with Waters Corporation narrowed the brand's scope: flow cytometry and lab diagnostics products moved to Waters, and BD became a focused MedTech brand across four segments.
Advertisement
About Becton, Dickinson and Company
What does BD make?
BD makes medical technology products: needles, syringes, catheters, blood collection systems, infusion pumps, medication dispensing systems, prefillable syringes for drug makers, and surgical and interventional devices.
Is BD publicly traded?
Yes. Becton, Dickinson and Company trades on the NYSE under ticker BDX and is a component of the S&P 500.
Did BD split up?
Yes. On February 9, 2026, BD completed the spin-off of its Biosciences and Diagnostic Solutions business and combined it with Waters Corporation. BD shareholders received approximately 0.135 Waters shares per BDX share, and BD received $4.0 billion in cash.
Who is the CEO of BD?
Tom Polen is Chairman, President, and Chief Executive Officer. He became CEO in January 2020 and chairman in 2021.
Advertisement
What is BD's revenue?
BD reported FY2025 revenue of $21.8 billion (fiscal year ended September 30, 2025), up 8.2% year over year. Post-separation, the continuing business reports on a New BD basis.
Who founded BD?
Maxwell W. Becton and Fairleigh S. Dickinson founded the company in 1897 in New York City. It incorporated in New Jersey in 1906.
- Founded: 1897
- Headquarters: Franklin Lakes, New Jersey, USA
- Company Type: Publicly Traded
- Stock: NYSE: BDX
- Revenue: $21.8 billion (FY2025, ended September 30, 2025)
- Employees: approximately 70,000
Where Is BD Made / Based?
- Headquarters: Franklin Lakes, New Jersey, USA
- Manufacturing / Operations: United States, Ireland, Mexico, Hungary
BD Categories & Tags
BD Sustainability & Ethics
BD's sustainability posture covers product safety, manufacturing emissions, and healthcare access programs. Its safety-engineered needle and Sharps lines are built around reducing needlestick injuries.
The brand operates under heavy quality regulation: FDA-registered manufacturing, ISO 13485 quality systems, and EU MDR compliance. Routine field corrections and recalls are a monitored part of the category's operating reality.
Advertisement
Awards & Recognition
- Fortune 500: Parent BD ranks among the largest US companies by revenue.
- Dividend record: Over 50 consecutive years of annual dividend increases.
BD Recalls & Controversies
Alaris remediation: The BD Alaris infusion system underwent a multi-year FDA remediation that restricted US sales from 2020, with 510(k) clearances progressing through 2023-2024.
Periodic recalls: BD issues occasional recalls and field corrections across syringes, catheters, and surgical products, handled through standard regulatory processes.
Ethylene oxide scrutiny: Sterilization facilities using ethylene oxide have drawn state environmental scrutiny and community concern, an industry-wide issue affecting medtech manufacturers.
Advertisement
BD Ownership: Pros & Cons
Advantages
- +Master brand of a focused pure-play MedTech company post-2026 separation
- +Over 90% recurring revenue from consumables
- +Category-leading positions in blood collection, dispensing, and infusion
- +Record FY2025 revenue of $21.8 billion
- +Deep clinical trust accumulated over more than a century
Considerations
- -Business-to-clinician brand with limited consumer recognition
- -Concentrated regulatory risk per product line, as Alaris showed
- -Separated the life sciences growth business to Waters
- -Demand tied to hospital capital budgets and procedure volumes
- -Structural device-liability and recall exposure
Frequently Asked Questions About BD
Advertisement
Sources & Further Reading
Competitors to BD
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Danaher | USA | 1935 | Mass market | Global | All Genders | |
| Boston Scientific | USA | 1979 | Mass market | Global | All Genders | |
| Danaher | USA | 1996 | Mass market | Global | All Genders | |
| Ge Healthcare | USA | 1994 | Premium | Global | All-ages | |
| Zimmer Biomet | USA | 2016 | Premium | Global | All Genders | |
| Stryker | USA | 1941 | Market leader | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsBeckman Coulter
Owned by Danaher Corporation
Danaher's clinical diagnostics operating company, supplying the analyzers, assays, and automation used in hospital and reference laboratories worldwide.
diagnosticslaboratory-instrumentsclinical-labs
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Healthcare PharmaceuticalsCepheid
Owned by Danaher Corporation
Molecular diagnostics company specializing in point-of-care PCR testing systems, owned by Danaher Corporation.
diagnosticsmolecular-testinginfectious-disease
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Healthcare PharmaceuticalsMonogram Technologies
Owned by Zimmer Biomet Holdings, Inc.
American orthopedic robotics company developing AI-navigated surgical robots for total knee arthroplasty, acquired by Zimmer Biomet in 2025 for approximately $177 million.
orthopedic-roboticssurgical-robotmedical-devices
Healthcare PharmaceuticalsStryker
Owned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
medical-devicesorthopaedicssurgical-equipment
Competitive Analysis
Market Positioning: BD competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to BD
Looking for brands with different ownership structures? These similar brands are not owned by Becton, Dickinson and Company, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike BD which is under a publicly traded parent company.
Healthcare PharmaceuticalsBenadryl
Owned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
antihistamineallergy-reliefcold-medicine
Privately Owned
Benadryl is privately owned, unlike BD which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoots
Owned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
pharmacyhealth-beautyuk-retail
Privately Owned
Boots is privately owned, unlike BD which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Publicly Traded
Boston Scientific operates independently without a large parent corporation.
Healthcare PharmaceuticalsDuane Reade
Owned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
pharmacydrugstorenew-york
Privately Owned
Duane Reade is privately owned, unlike BD which is under a publicly traded parent company.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Publicly Traded
GE HealthCare operates independently without a large parent corporation.
Becton, Dickinson and Company Stock Information
Advertisement
Jobs at Becton, Dickinson and Company
Latest News About BD
Advertisement
Related Articles About BD
View more articles
News & Updates
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Who Brands StaffNov 6, 2026
Ipo RoundupIpoStock Market
News & Updates
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Who Brands StaffNov 6, 2026
M And A RoundupAcquisitionsNews
Rivalry
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Who Brands StaffOct 23, 2026
DuracellEnergizerRivalry
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Branddermatology
Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.
Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription